- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01034761
Using Clinical Alerts to Decrease Inappropriate Medication Prescribing
Using Clinical Alerts in a Computerized Provider Order Entry System to Decrease Inappropriate Medication Prescribing Among Hospitalized Elders
Introduction:
The Beers list identifies medications that should be avoided in persons 65 years or older because they are ineffective, pose an unnecessarily high risk, or a safer alternative is available. In a recent study, we found a high rate of prescribing of Beers list medications to hospitalized patients. At Baystate, 41% of medical patients received at least one Beers list drug classified as "high severity," meaning it carried a high risk for an adverse drug reaction, while 5% received 3 or more. Some Beers drugs have been associated with delirium and falls. When compared to Baystate patients who did not receive a high severity medication, those who did had an increased risk of mortality (7.8% vs. 5.2%), longer length of stay (5.5 days vs. 3.9 days) and higher costs ($11,240 vs. 6243).
Specific Aims:
- Quantify the impact of synchronous electronic alerts on physician prescribing of high-severity Beers' list drugs to hospitalized patients over the age of 65 years.
- Compare physician reactions to each drug-specific alert
Project Description:
We will develop a series of clinical alerts in CIS, Baystate's computerized provider order entry system, to reduce the use of potentially inappropriate medications among hospitalized elders. We will randomize providers to electronic alerts or usual care. Whenever a provider randomized to alerts attempts to place an order for a high-risk medication on the Beers list and the intended recipient is over 65 years of age, a synchronous alert (i.e. a "pop-up") will inform the physician about the risks associated with the medication and will propose safer alternatives.
We will collect data on physician ordering and patient outcomes comparing the number of Beers list prescriptions from providers receiving electronic alerts to those not receiving alerts. Our anticipated outcome is a decrease in inappropriate prescribing during the period when the electronic alerts are activated. Other potential outcomes include decrease in length of stay and a decrease in falls.
Studie Overzicht
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Massachusetts
-
Springfield, Massachusetts, Verenigde Staten, 01199
- Baystate Medical Center
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Hospitalized patients with Age > 65
Exclusion Criteria:
- None
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Geen tussenkomst: Gebruikelijke zorg
|
|
|
Experimenteel: Pop-up alerts
Providers will receive pop-up alerts in the electronic medical record when prescribing one of the specified medications from the Beers list.
|
Pop-up alert in the electronic medical record whenever the provider enters an order for a specified high risk medication from the Beers list.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
The percentage of elderly patients who receive a specified high-risk medication from the Beer's list.
Tijdsspanne: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
The average number of specified high risk medications prescribed per patient.
Tijdsspanne: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Restraint use
Tijdsspanne: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Falls
Tijdsspanne: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Length of stay
Tijdsspanne: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Total Cost
Tijdsspanne: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Discharge status
Tijdsspanne: 6 months
|
6 months
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Linda J Canty, MD, Baystate Medical Center
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- 132454
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Pop-up alert
-
Children's Hospitals and Clinics of MinnesotaVoltooidLicht hoofdletselVerenigde Staten
-
Poitiers University HospitalNog niet aan het werven
-
Dana-Farber Cancer InstituteVoltooidBorstkanker | Maagdarmkanker | Orale kankergerichte therapie | Orale chemotherapieVerenigde Staten
-
University Of PerugiaVoltooidUrine-incontinentie | Verzakking van het bekkenorgaanItalië
-
University of Colorado, DenverWervingHoog herfstrisicoVerenigde Staten
-
Ankara City Hospital BilkentWervingPreoperatieve angst | Ontwijkingsdelirium in Pediatrische AnesthesieTurkije (Türkiye)
-
University of CincinnatiChildren's Hospital Medical Center, Cincinnati; The Kroger CompanyVoltooidHypertensie | Obesitas | Dieet Wijziging | HyperlipidemieVerenigde Staten
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...WervingMetabole disfunctie-geassocieerde steatotische leverziekteVerenigde Staten
-
Medical University of South CarolinaSouth Carolina Clinical & Translational Research Institute (SCTR)Actief, niet wervendTabaksgebruiksstoornisVerenigde Staten